Methods Eligibility criteria The PICOS strategy was defined as follows: P (participants) human subjects, I (interventions) oral LC treatment, C (comparisons) between supplementation and placebo, supplementation and control, or pre- and post- supplementation, O (outcomes) muscle variables, and S (study design) randomized controlled trials, non-randomized controlled trials, non-randomized non-controlled trials
Advances in Lipid Nanocarrier Design and Encapsulation Efficiency Modern liposomal systems have moved beyond traditional thin-film hydration methods toward microfluidic and high-pressure homogenization techniques, which enable more precise control of particle size, encapsulation efficiency, and scalability
A practical design path often involves defining, at an early stage, which modules are essential and which can be omitted without losing the core mechanism [21, 53]
Its stability in gastric acid also makes it orally active, a rarity among peptides
L-Carnitine is essential for transporting fatty acids into your cells' mitochondria where they're converted into energy
It enhances cellular migration and recovery at the injury site